More progress in detecting oesophageal cancer early - Cancer Research UK - Cancer news
SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus | BMC Cancer | Full Text
A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction - Annals of Oncology
Oesophageal cancer: risks, prevention, and diagnosis | The BMJ
Oesophageal cancer risk | Cancer Research UK
Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial - The Lancet Gastroenterology & Hepatology
Cancers | Free Full-Text | The Landscape of CAR-T Cell Clinical Trials against Solid Tumors—A Comprehensive Overview
Advances in targeted therapy for esophageal cancer | Signal Transduction and Targeted Therapy
Peri-operative therapy for operable gastroesophageal adenocarcinoma: past, present and future - Annals of Oncology
COG : Gefitinib for oesophageal cancer progressing after chemotherapy — Department of Oncology
Frontiers | VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2 ...
About Us — Department of Oncology
Oesophageal cancer incidence statistics | Cancer Research UK
Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial - The Lancet Oncology
The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 -
Oesophageal cancer risk | Cancer Research UK
A trial looking at improving chemoradiotherapy for people with cancer of the food pipe (SCOPE 2) | Cancer Research UK
Oesophageal carcinoma - The Lancet
Cell-free DNA analysis in current cancer clinical trials: a review | British Journal of Cancer
Treatment pattern and overall survival in esophageal cancer during a 13-year period: A nationwide cohort study of 6,354 Korean patients | PLOS ONE
Regulatory and clinical consequences of negative confirmatory trials of accelerated approval cancer drugs: retrospective observational study | The BMJ
Clinical evidence for association of neoadjuvant chemotherapy or chemoradiotherapy with efficacy and safety in patients with resectable esophageal carcinoma (NewEC study) - eClinicalMedicine
Barrett's oesophagus | Signs and symptoms - Macmillan Cancer Support
Men's oesophageal cancer risk "triple that of women" - PMLiVE
Frontiers | “Targeted” Chemotherapy for Esophageal Cancer
Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
Advances in the curative management of oesophageal cancer | British Journal of Cancer
.jpg?csf=1&web=1&e=dTEB7V "Immune boosting antibody trialled in patients with oesophageal cancer | Southampton Clinical Trials Unit | University of Southampton")